3 Strong Buy Stocks Under $10

Last week, the S&P 500 marked a modest 0.31% gain, driven primarily by mega-cap performance and better-than-expected results as we enter into the final stretch of earnings season. 

This marks the 6th consecutive week of closing in the green for the benchmark index — but it hasn’t exactly been smooth sailing. To be precise, a 1.23% pullback on Friday, primarily driven by selloffs in the tech sector, hints that we’re not going to see any easy trades soon, particularly among the big names.

All in all, we have strong earnings results and decently positive sentiment. The market does have reasons to keep grinding higher — but the crowded trades are vulnerable.

So, what do you do in situations like these? You look where others aren’t looking. Across the exchanges, there are plenty of tickers with fundamentals that put most high-profile stocks to shame. Those tickers are ignored for one reason or another — and oftentimes, that reason is price.

Not that they’re too expensive — the opposite. Cheap stocks are often associated with speculative, volatile businesses, but that isn’t always the case. There’s a wide range of opportunities there — provided that you know how to find the right picks. And the best way to go about it is by turning to …

Under $10 Stock Strategy

Our proprietary quant rating system grades 4,600 stocks every single day through the lens of 115 unique metrics and factors. This provides a deep, balanced overview of a stock’s fundamentals, and it’s all distilled into a simple, intuitive metric — a stock’s Zen Rating.

A Zen Rating of A, equivalent to a Strong Buy, is only given to the top 5% of stocks. While that’s a great start, it does leave you with roughly 230 stocks to consider on any given day. Thankfully, you can narrow the search down even further — by taking a look at one of our exclusive Zen Strategies.

These are 11 meticulously-crafted stock portfolios, each consisting of just 7 tickers selected to deliver outsized returns. Today, we’ll be taking a look at one of our top-performing portfolios of 2026. 

Despite the market downturn, it has provided a 22.4% return since the start of the year — and it’s also managed to secure a 2.82% gain in the past 30 days, while the S&P 500 slipped by 4.84% in the same timeframe. Without further ado, let’s dig into 3 interesting tickers from our Under $10 Stock Strategy.

Xeris Biopharma (XERS)

First up is Xeris Biopharma, a commercial-stage drugmaker focused on endocrinology and neurology.  XERS currently ranks in the top 3% of the stocks that we track, giving it a Zen Rating of A.

There are 3 areas where the stock shines — Financials, Value, and Growth. When it comes to Financials, Xeris Biopharma ranks in the top 12%, indicating a pretty healthy balance sheet. In terms of Value, it’s in the top 11%, and the stock is currently trading at PEG of 0.86x. Finally, we have Growth — a category where XERS ranks in the top 6% in, thanks primarily to a 103.78% earnings growth forecast for the next 12 months.

While the Sentiment reading is a C, XERS ranks as above-average in that category. Safety comes in at a slightly above average, in the 58th percentile. Momentum is the real drawback here — Xeris Biopharma is currently trading at $6.24, far off from its 52-week high of $10.

In fact, the stock has also lost about 5.8% in value since its latest earnings report on May 7, which was a beat. While it isn’t a major dip, more a classic case of profit-taking after a run-up, with the valuation being as attractive as it is, there’s no particular reason to wait for a better entry point.

Pyxis Tankers (PXS)

Our second pick is Pyxis Tankers, a maritime shipping company that owns and operates tankers. Its fleet transports refined petroleum products and other bulk liquids across global trade routes. Right now, PXS ranks in the top 2% of all the stocks that we track.

What immediately stands out is just how well-rounded the Component Grade profile is. There are 7 Component Grades in total — and Pyxis gets 2 A ratings, 3 B ratings, and 2 C ratings.

In terms of Momentum, PXS ranks in the top 5%, thanks to a 31.42% rally in the past 3 months. Our Artificial Intelligence rating uses a neural network trained on 20 years of market data to spot likely outperformers — in this category, PXS is in the top 2%. To boot, the stock ranks in the top 6% for Value, the top 15% for Sentiment, and the top 20% for Growth.

Now, where things are a little less stellar are Financials and Safety. Financials read as slightly above-average, but Safety is the true issue here. This is a player in a cyclical industry, so the rating reflects that. Not a red flag per se, but definitely something to be keenly aware of.

So, why now? PXS has been trading sideways since late March. The fundamentals, particularly the strong Growth rating and the fact that the stock isn’t overvalued, all suggest that the rally will eventually continue. On top of that, the macro backdrop is, for the time being at least, favorable for PXS.

VTEX (VTEX)

Our third and final pick is VTEX. They run a digital commerce platform that helps brands, retailers, and manufacturers build and manage online storefronts, marketplaces, order systems, and customer experiences. VTEX ranks in the top 2% of the stocks that we track, and it’s currently the 3rd highest rated stock in the App industry, which has an Industry Rating of B.

The areas of strength here are Growth, Financials, and Sentiment. For Growth, VTEX is in the top 12%, thanks to an average 12-month earnings growth forecast of 33.06%. In terms of Financials, it’s in the top 16%. Lastly, we have Sentiment — here, it’s in the top 11%, since the average Wall Street analyst price target implies a 28.17% upside.

Value and Safety read as above-average, but not exceptional. Top 28% for Value, top 26% for Safety. The one area where the stock is legitimately underwhelming is Momentum, where it ranks in the bottom 42%. VTEX has lost around 12% in value in the last 30 days — on the flip side, since the other fundamentals are so strong, this is a great opportunity to buy the dip.

Another point in VTEX’s favor is strong execution. The company has beaten EPS estimates for 5 quarters in a row. In 4 of those quarters, year-over-year (YoY) EPS growth was in the triple-digits, and not because earnings were previously depressed and then recovered. It might take a while, but if you’ve got the patience, the fundamentals are hard to beat.

Interested In More Great Stock Picks? 

The 3 stocks highlighted above are just a fraction of what you get from our proven Under $10 Stock Strategy.

That’s because each day our system recalibrates — and Zen Strategies members get access to the top 7 technology stocks based on 115 different parameters that point to outperformance. 

See all Top 7 Under $10 Stocks here >

However, maybe income stocks aren’t what you’re after right now. Perhaps you would like to see all 11 of our market beating strategies including Growth, Momentum, Value, and our coveted AI Factor model. 

Each featuring the top 7 stocks.

Each featuring tremendous performance

We spell it all out in this timely presentation below that lives up to its name:

10 Minutes a Month to Beat the Market > 

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.